Pharma Journalist -

Lonza Sales AG, through its Bioscience Division, and Sanquin Reagents B.V. have entered into a strategic partnership for the commercialization of a range of specialized reagents for…
Read More...

Bird Rock Bio, Inc., a clinical stage biopharmaceutical company, announced that the Company has filed an investigational new drug (IND) application with the U.S. Food and Drug…
Read More...

Advent Srl, an IRBM company and global leader in viral vector manufacturing, announces it has manufactured 13,000 doses of the novel Covid-19 vaccine candidate, ChAdOx1 nCoV-19 (now…
Read More...

AveXis, a Novartis company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending…
Read More...

GlaxoSmithKline plc (GSK) announced that the US Food and Drug Administration (FDA) has granted a priority review for the company’s application seeking approval of Nucala (mepolizumab)…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has approved Zeposia (ozanimod) for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS)…
Read More...

Novavax, Inc. announced the acquisition of Praha Vaccines a.s., part of the Cyrus Poonawalla Group, in an all cash transaction of approximately $167 million. The acquisition includes a…
Read More...

Rentschler Biopharma SE announced that the company has entered into a strategic collaboration with Genmab for the process development and manufacture of bispecific antibodies generated…
Read More...

Gilead Sciences, Inc. and Arcus Biosciences, Inc. announced that the companies have entered into a 10-year partnership to co-develop and co-commercialize current and future therapeutic…
Read More...

PhaseBio Pharmaceuticals, Inc. announced FDA authorization to proceed with VANGARD, a potentially pivotal clinical trial to evaluate PB1046 as a treatment for hospitalized COVID-19…
Read More...